We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Imports/Exports Lower; Morgan Stanley, Abbott Beat in Q3
Read MoreHide Full Article
Wednesday, October 16th, 2024
This morning, we see a new print on international trade as well as further articulation on Q3 earnings, particularly in banking/finance and Big Pharma. Pre-market futures are slightly up at this hour: the Dow +22 points, the S&P 500 +1 and the Nasdaq +5 points. Both the Dow and S&P made all-time closing highs Monday afternoon.
Import Prices Mixed in September
The latest headline on Import Prices for last month came in this morning at -0.4%. This is 10 basis points (bps) below expectations, which is also where we saw this print a month ago, -0.3%. This is the deepest cut so far in 2024, the lowest since December. Ex-fuel costs (to remove volatility), we see the core figure swing back to +0.2% on import pricing, matching May but still off the near-term high of +0.6% back in April.
Exports also came in lower than anticipated: -0.7%, from the -0.5% consensus estimate. This -0.7% has now been hit for the second-straight month, as well as the fourth negative print in the past five months. Before that, Exports had been in the green the previous four months.
Q3 Earnings Stock Roundup: ABT, MS, USB
Medical devices and diagnostics specialist Abbott Labs (ABT - Free Report) reported a one-cent beat on earnings for its Q3 report this morning, for earnings of $1.21 per share. Revenues in the quarter reached $10.6 billion, led by +13% growth in Devices. Next-quarter earnings are still within the range of the Zacks consensus, and pre-market shares are flat; ABT is up +5% year to date.
Morgan Stanley (MS - Free Report) keeps the strong performance of Wall Street finance intact this quarter, posting a +20% beat to $1.88 earnings per share, 50-cents higher than the year-ago print of $1.38 per share. Revenues came in nicely ahead of projections: $15.38 billion versus $14.27 billion estimated and $13.27 billion reported in the year-ago quarter. Shares are up +2.7% in early trading, adding to the stock’s +20% gains year to date. For more on MS’ earnings, click here.
U.S. Bancorp (USB - Free Report) was mixed in its Q3 results out this morning: earnings of $1.03 per share beat the Zacks consensus by three cents, on revenues in the quarter of $6.83 billion — beneath the $6.88 billion expected, for a -0.68% negative surprise. Lending Income performed nicely in Q3, and shares are +2.7% in early trading, pushing the stock to double-digit gains year to date. For more on USB’s earnings, click here.
With Import/Export Prices already reported this morning, we do not expect any other monthly reports to hit the tape for the remainder of this Wednesday. Nor will we hear from any Fed members regarding their views on further interest rates. (The next Fed meeting begins the day after Election Day, November 6th, and ends the following day with an expected 25 bps cut to the Fed funds rate, to +4.50-4.75%.) After the close, we’ll see earnings from CSX (CSX - Free Report) and Las Vegas Sands (LVS - Free Report) , among many others. Questions or comments about this article and/or author? Click here>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Imports/Exports Lower; Morgan Stanley, Abbott Beat in Q3
Wednesday, October 16th, 2024
This morning, we see a new print on international trade as well as further articulation on Q3 earnings, particularly in banking/finance and Big Pharma. Pre-market futures are slightly up at this hour: the Dow +22 points, the S&P 500 +1 and the Nasdaq +5 points. Both the Dow and S&P made all-time closing highs Monday afternoon.
Import Prices Mixed in September
The latest headline on Import Prices for last month came in this morning at -0.4%. This is 10 basis points (bps) below expectations, which is also where we saw this print a month ago, -0.3%. This is the deepest cut so far in 2024, the lowest since December. Ex-fuel costs (to remove volatility), we see the core figure swing back to +0.2% on import pricing, matching May but still off the near-term high of +0.6% back in April.
Exports also came in lower than anticipated: -0.7%, from the -0.5% consensus estimate. This -0.7% has now been hit for the second-straight month, as well as the fourth negative print in the past five months. Before that, Exports had been in the green the previous four months.
Q3 Earnings Stock Roundup: ABT, MS, USB
Medical devices and diagnostics specialist Abbott Labs (ABT - Free Report) reported a one-cent beat on earnings for its Q3 report this morning, for earnings of $1.21 per share. Revenues in the quarter reached $10.6 billion, led by +13% growth in Devices. Next-quarter earnings are still within the range of the Zacks consensus, and pre-market shares are flat; ABT is up +5% year to date.
Morgan Stanley (MS - Free Report) keeps the strong performance of Wall Street finance intact this quarter, posting a +20% beat to $1.88 earnings per share, 50-cents higher than the year-ago print of $1.38 per share. Revenues came in nicely ahead of projections: $15.38 billion versus $14.27 billion estimated and $13.27 billion reported in the year-ago quarter. Shares are up +2.7% in early trading, adding to the stock’s +20% gains year to date. For more on MS’ earnings, click here.
U.S. Bancorp (USB - Free Report) was mixed in its Q3 results out this morning: earnings of $1.03 per share beat the Zacks consensus by three cents, on revenues in the quarter of $6.83 billion — beneath the $6.88 billion expected, for a -0.68% negative surprise. Lending Income performed nicely in Q3, and shares are +2.7% in early trading, pushing the stock to double-digit gains year to date. For more on USB’s earnings, click here.
What to Expect for Hump Day in the Stock Market
Check out the updated Zacks Earnings Calendar here.
With Import/Export Prices already reported this morning, we do not expect any other monthly reports to hit the tape for the remainder of this Wednesday. Nor will we hear from any Fed members regarding their views on further interest rates. (The next Fed meeting begins the day after Election Day, November 6th, and ends the following day with an expected 25 bps cut to the Fed funds rate, to +4.50-4.75%.) After the close, we’ll see earnings from CSX (CSX - Free Report) and Las Vegas Sands (LVS - Free Report) , among many others.
Questions or comments about this article and/or author? Click here>>